• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Technology
    • AI
    • History of Otolaryngology
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
    • SUO Corner
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Psychophysical Testing of Chemosensory Function During COVID-19 Infection Shows Recovery Trend

by Linda Kossoff • May 19, 2021

  • Tweet
  • Email a link to a friend (Opens in new window) Email
Print-Friendly Version

What will extensive psychophysical tests performed during the course of COVID-19 disease reveal about chemosensory dysfunction and recovery?

BOTTOM LINE

You Might Also Like

  • Large-Scale Study Reveals Significant Impact of COVID-19 on Olfactory and Gustatory Function
  • No Correlation Between SARS- CoV-2 Viral Load and Olfactory Psychophysical Scores in COVID-19 Patients
  • Testing for Decreased Smell Function May Help Identify Coronavirus Patients Earlier
  • Smell and Taste Disorder Differences Seen Between Long-Term COVID-19 and non-COVID-19 Patients
Explore This Issue
May 2021

Chemosensory dysfunction is very common in COVID-19 and, although most people regain function within the first 28 days, a quarter of patients show persisting chemosensory dysfunction.

BACKGROUND: Although smell and taste dysfunction are among the most common symptoms of COVID-19, most studies on chemosensory dysfunction in COVID-19 are based on subjective findings. Objective psychophysical tests done during the infection could provide a reliable evaluation of chemosensory function and recovery over the course of the disease.

STUDY DESIGN: Prospective cohort study.

SETTING: Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Germany; Center for Rhinology and Allergology, Wiesbaden, Germany; Department of Otolaryngology, Head and Neck Surgery, Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians University, Munich, Germany; and Department of Otolaryngology, University of Foggia, Italy.

SYNOPSIS: Researchers conducted chemosensory tests on 111 confirmed COVID-19 patients (59 males, 52 females, mean age 44.5 years). Participants were tested within three days of diagnosis, and at different time points according to each location’s schedule (mean days post infection 62.9 days). Two methods of gustatory testing were used, as available: the simple Taste Sprays tool and the more detailed Taste Strips. For testing olfactory function, examiners used two evaluation methods by Sniffin’ Sticks for threshold, discrimination, and identification abilities, as available on site. Statistical analysis revealed significant differences in olfactory function during infection (21% anosmic, 49% hyposmic, 30% normosmic) and after infection (1% anosmic, 25% hyposmic, 74% normosmic). Gustatory function tested with Taste Strips also showed significant differences during and after infections; Taste Spray screening results did not. Combined, gustatory tests showed a functional reduction from 26% during infection to 6.5% post infection. Results indicated that most people with COVID-19-associated chemosensory dysfunction regain smell and taste within 28 days, but up to a quarter of patients exhibit a longer-lasting dysfunction. Limitations included a limited number of participants for detailed gustatory function testing.

CITATION: Niklassen AS, Draf J, Huart C, et al. COVID-19: Recovery from chemosensory dysfunction. A multicentre study on smell and taste. Laryngoscope. 2021;131:1095-1100.

Filed Under: COVID19, Literature Reviews, Otology/Neurotology, Practice Focus Tagged With: COVID19, treatmentIssue: May 2021

You Might Also Like:

  • Large-Scale Study Reveals Significant Impact of COVID-19 on Olfactory and Gustatory Function
  • No Correlation Between SARS- CoV-2 Viral Load and Olfactory Psychophysical Scores in COVID-19 Patients
  • Testing for Decreased Smell Function May Help Identify Coronavirus Patients Earlier
  • Smell and Taste Disorder Differences Seen Between Long-Term COVID-19 and non-COVID-19 Patients

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you think GLP-1s are the next big disruptors in ENT practice?

View Results

Loading ...
  • Polls Archive

Top Articles for Residents

  • The Example We Set: Thoughts on the End of Residency Training
  • Is the SLOR in Otolaryngology Residency Applications Contributing to Rural Disparities?
  • Applications Open for Resident Members of the ENTtoday Editorial Board: Deadline Extended
  • A Resident’s View of AI in Otolaryngology
  • Call for Resident Bowl Questions
  • Popular this Week
  • Most Popular
  • Most Recent
    • How GLP-1s Are Changing Otolaryngology Practice
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • History of the Cochlear Implant
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment
    • Complications for When Physicians Change a Maiden Name
    • Facial Nerve Paralysis: Protecting the Eye and Restoring Function
    • Multi-Institutional Validation of the Interarytenoid Assessment Protocol for Pediatric Laryngeal Cleft
    • DB-OTO Gene Therapy for Inherited Deafness
    • Wearable AR for Nystagmus Examination in Patients with Vertigo: Randomized Crossover Usability Study
    • Increased Prevalence of Hearing Loss and Tinnitus in Patients with Retinal Vein Occlusion

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939